文献速递主动脉外科瓣膜外科

马凡综合征主动脉根部手术中期结局:前瞻性多中心比较研究

Midterm outcomes of aortic root surgery in patients with Marfan syndrome: A prospective, multicenter, comparative study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-09-04

本研究为前瞻性国际多中心注册研究,纳入316例符合严格Ghent诊断标准的马凡综合征患者,比较主动脉瓣置换根部替换(AVR)与保留主动脉瓣根部替换(AVS)的中期结局。中位临床随访64个月,两组生存率相似(AVR 88.2%±4.4% vs AVS 95.0%±1.5%,P=.1)。倾向评分校正竞争风险模型显示AVS与更高的主要不良瓣膜相关事件、瓣膜相关发病率、结构性瓣膜退化合并非结构性瓣膜功能障碍及主动脉瓣反流≥2+累积发生率相关(均P<.01)。

要点

  • AVS与AVR中期生存率相似,无显著差异。
  • AVS主要不良瓣膜相关事件及瓣膜相关发病率更高。
  • 差异主要源于AVS组更频繁的主动脉瓣功能障碍。

核心结论

  • 术后五年,AVS组主要不良瓣膜相关事件和瓣膜相关发病率高于AVR组,主要因主动脉瓣功能障碍更频繁。
  • 两组在生存率、瓣膜相关死亡率、主动脉瓣再干预或出血方面无差异。

研究设计与样本

  • 前瞻性、多中心、国际注册研究,纳入符合严格Ghent诊断标准的马凡综合征患者。
  • 共316例患者入组,AVR组77例,AVS组239例;214例重新同意20年随访。

主要发现

  • 存活患者中位临床随访时间为64个月(四分位距42-66个月)。
  • AVR组和AVS组生存率分别为88.2%±4.4%和95.0%±1.5%(P=.1)。
  • 倾向评分校正竞争风险模型显示AVS与更高的主要不良瓣膜相关事件、瓣膜相关发病率、结构性瓣膜退化合并非结构性瓣膜功能障碍及主动脉瓣反流≥2+累积发生率相关(均P<.01)。
  • 再干预(P=.7)、出血(P=.2)、栓塞(P=.3)或瓣膜相关死亡率(P=.8)无差异。

关键数值与推荐

  • 马凡综合征诊断采用严格Ghent标准。
  • 主要终点包括主要不良瓣膜相关事件、瓣膜相关发病率、结构性瓣膜退化合并非结构性瓣膜功能障碍、主动脉瓣反流≥2+、再干预、出血、栓塞及瓣膜相关死亡率。

临床怎么用

  • 在马凡综合征患者中,AVS与AVR中期生存率相似,但AVS需关注更高的瓣膜相关事件风险,尤其是主动脉瓣功能障碍。
  • 临床决策应权衡AVS避免抗凝的潜在获益与瓣膜功能障碍风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to compare midterm outcomes of aortic valve-replacing root replacement (AVR) and aortic valve-sparing root replacement (AVS) operations in patients with Marfan syndrome. METHODS: Patients who met strict Ghent diagnostic criteria for Marfan syndrome and who underwent either AVR or AVS between March 1, 2005 and December 31, 2010 were enrolled in a 3-year follow-up prospective, multicenter, international registry study; the study was subsequently amended to include 20-year follow-up. Enrollees were followed clinically and echocardiographically. RESULTS: Of the 316 patients enrolled, 77 underwent AVR and 239 underwent AVS; 214 gave reconsent for 20-year follow-up. The median clinical follow-up time for surviving patients was 64 months (interquartile range, 42-66 months). Survival rates for the AVR and AVS groups were similar at 88.2% ± 4.4% and 95.0% ± 1.5%, respectively (P = .1). Propensity score-adjusted competing risk modeling showed associations between AVS and higher cumulative incidences of major adverse valve-related events, valve-related morbidity, combined structural valve deterioration and nonstructural valve dysfunction, and aortic regurgitation ≥2+ (all P < .01). No differences were found for reintervention (P = .7), bleeding (P = .2), embolism (P = .3), or valve-related mortality (P = .8). CONCLUSIONS: Five years postoperatively, major adverse valve-related events and valve-related morbidity were more frequent after AVS than after AVR procedures, primarily because of more frequent aortic valve dysfunction. No between-group differences were found in rates of survival, valve-related mortality, reintervention on the aortic valve, or bleeding. We plan to follow this homogenous cohort for 20 years after aortic root replacement.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Coselli JS, Volguina IV, LeMaire SA, et al. Midterm outcomes of aortic root surgery in patients with Marfan syndrome: A prospective, multicenter, comparative study. J Thorac Cardiovasc Surg. 2021. PMID: 34629178. doi:10.1016/j.jtcvs.2021.08.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。